HSKA - Heska to Present at Three Upcoming Institutional Investor Conferences

PR Newswire

LOVELAND, Colo. , Feb. 23, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that members of Heska's management team will present at three institutional investor conferences in March 2023 .

• Bank of America Securities 2023 Animal Health Summit, March 2 . Kevin Wilson , Chief Executive Officer and President, will participate in a virtual fireside discussion at 1:20 p.m. ET .
  
  
• Raymond James Virtual 44 ^th Annual Institutional Investors Conference, March 7 .  Mr. Wilson will present at 2:15 p.m. ET and the presentation will be immediately followed by a question and answer session.
  
  
• Barclays Global Healthcare Conference, March 14 .  Catherine Grassman, Executive Vice President, Chief Financial Officer, will participate in a fireside discussion at 3:05 p.m. ET .

Company management will also participate in one-on-one meetings at each event. Event webcasts and presentations can be accessed through the links provided on the Heska Investor Relations website, https://ir.heska.com/events/ . For additional information, please contact Heska Investor Relations at investorrelations@heska.com .

About Heska

Heska Corporation (NASDAQ: HSKA) sells, manufactures, markets, and supports diagnostic and specialty products and solutions for veterinary practitioners. Heska's portfolio includes point-of-care diagnostic laboratory instruments and consumables including rapid assay diagnostic products and digital cytology services; point-of-care digital imaging diagnostic products; local and cloud-based data services; practice information management software ("PIMS") and related software and support; reference laboratory testing; allergy testing and immunotherapy; heartworm preventive products; and vaccines. Heska's primary focus is supporting companion animal veterinarians in providing care to their patients. Heska's business is composed of two operating and reportable segments: North America and International. North America consists of the United States , Canada and Mexico . International consists of geographies outside of North America , primarily in Germany , Italy , Spain , France , Switzerland , Australia and Malaysia . The Company's strategic focus on point-of-care diagnostic laboratory and imaging products is included in both segments. The North America segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory, and the International segment includes PIMS business and veterinary laboratories. For more information, please visit www.heska.com .

SOURCE Heska Corporation